NEW DELHI: Haleon, formerly GSK Consumer Healthcare, will invest about Rs 2,000 crore (£175 million) to establish its first manufacturing facility in India, underscoring the country's position as one of the company's fastest-growing markets globally.

Haleon announces ₹2,000 crore investment to establish its first manufacturing facility in India, enhancing local oral care production and exports.

Haleon, the maker of Sensodyne, will invest £175 million to build its first oral health manufacturing plant in India, signaling strong confidence in the country's market potential.

NEW DELHI: Haleon, formerly GSK Consumer Healthcare, will invest about Rs 2,000 crore (£175 million) to establish its first manufacturing facility in India, underscoring the…